MADRID — Results of a Phase 3 trial of Moderna and Merck’s closely watched cancer vaccine were released on Thursday, after the data were leaked earlier …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.